The global kyphosis market is anticipated to grow at a compound annual growth rate of 11.4 percent between 2016 and 2022, based on a Market Research Future report, according to Yahoo! Finance.
Here are five observations:
1. An increasing number of patients impacted by kyphosis is driving the development of new treatments.
2. The prevalence of kyphosis in older adults ranges from 20 percent to 40 percent.
3. North America currently accounts for the largest market share.
4. The Asia-Pacific region is expected to witness the most rapid market growth.
5. Bmkorea, Taeyeon Medical Co., Surgi R&D, Depromed, EC21 and Otis Biotech Korea, all located in the Republic of Korea, are key market players. Dublin, Ireland-based Medtronic is also considered a leader in the space.